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PW tissue doppler echocardiography measurements of the lateral wall
Variables Patients (n¼50) Control (n¼47) P value
Sm (cm/s) 7.9  1.6 10.4  2.4 <0.001
Em (cm/s) 10.2  3.3 14.4  3.2 <0.001
Am (cm/s) 9.5  2.1 10.3  2.4 0.09
Em/Am ratio 1.1  0.4 1.4  0.4 <0.001
IVCT (ms) 69.1  13.9 67.8  13.5 0.641
ETm (ms) 299  27.8 292  26.5 0.172
IVCTm/ETm ratio 0.22  0.04 0.22  0.4 0.958
IVRTm (ms) 78.8  12.4 65.8  10.6 <0.001
MPI 0.49  0.08 0.45  0.07 0.008
Sm, systolicmyocardial wave; Em, early diastolicmyocardialwave; Am, late diastolicmyocardial
wave; IVCTm,myocardial isovolumetric contraction time; ETm:myocardial ejektion time; IVRTm,
myocardial isovolumetric contraction time; MPI, myocardial performance index
Aortic elastic echocardiographic parameters
Variables Patient (n¼50) Control (n¼47) P value
AoSD (mm) 29.3  3.8 30.6  2.8 0.01
AoDD (mm) 26.6  3.8 26.6  2.6 0.961
Aortik strain (%) 6.4  2.2 14.3  4.5 <0.001
Aortik distensibility
10-3 cm2 dyn-1
2.7  1.1 7.1  3.2 <0.001
AoSD: aortic systolic diameter, AoDD: aortic diastolic diameter
Correlations between elastic parameters and left ventricle tissue Doppler
echocardiographic parameters
Variables
Aortic strain
coefﬁcient
Aortic
strain
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Aim: Sjogren's syndrome (SS) is a chronic autoimmune disease characterized by
mouth and eye dryness and caused by lymphocyte inﬁltration of salivary and lacrimal
glands. Capable of multi-organ involvement in SS, a cardiac ﬁndings of pulmonary
effusion, left ventricular diastolic dysfunction and pulmonary hypertension common
ﬁndings. Aortic stiffness (AS) reﬂects the mechanical tension and elasticity of aorta. In
this study, our aim is to determine if there is any difference in AS and left ventricular
function between patients diagnosed as SS and healthy control groups.
Methods: We enrolled 50 patients with SS and 47 healthy volunteers with similar
demographic characteristics. Left ventricular systolic and diastolic function were
assessed with two dimensional (2D) echocardiography, M-mode echocardiography,
pulsed-wave (PW) echocardiography and tissue Doppler echocardiography and
myocardial performance index (MPI) was calculated. The diameter of ascending aorta
was measured by M-mode echocardiography at a level 3 cm above the aortic valve.
Results: When mitral diastolic ﬂow rates were analyzed, it was found that iso-
volumetric relaxation time (IVRT) and deceleration time (DT) were signiﬁcantly
longer and E wave was signiﬁcantly lower in patients with SS, but there was no
difference in the other parameters. When TDE ﬁndings for left ventricular lateral wall
were compared between two groups, it was found that Sm, Em and Em/ Am ratio were
signiﬁcantly lower, and myocardial isovolumetric relaxation time (IVRTm) and MPI
values were signiﬁcantly higher in patients with SS. A signiﬁcant positive correlations
between aortic strain and Sm (r¼0.35, p<0.001), Em (r¼0.42, p<0.001) and Em/Am
(r¼0.26, p¼0.008) and negative correlations IVRTm (r¼-0.36, p<0.001) and MPI
(r¼ -0.24, p¼0.01) were detected. A signiﬁcant positive correlations between aortic
distensibility and Sm (r¼0.36, p<0.001), Em (r¼0.44, p<0.001), Em/Am (r¼0.26,
p¼0.009) and negative correlation IVRTm (r¼ -0.22, p¼0.02) were determined.
Conclusıon: There is a signiﬁcant relationship between aortic stiffness and left
ventricular diastolic dysfunction in patients with SS in this study. The parameters of
aortic elasticity measured by 2D echocardiographic methods can be beneﬁcial in
predicting early cardiovascular risk in SS.Control group and baseline characteristics of patients with sjogren
Variables Patients (n¼50) Control (n¼47) P value
Age (year) 42.8  8.3 40.1  8.0 0.114
Gender (F/M) 47/3 41/6 0.256
BMI (kg/m2) 27.9  4.9 27.0  3.6 0.344
SBP (mmHg) 122.3  12.4 118.6  11.5 0.136
DBP (mmHg) 74.3  8.7 73.5  8.2 0.625
Pulse (beats/minute) 77.5  11.8 75.8  10.4 0.459
Cigarette (%) 14 16 0.377
PW echocardiographic measurements of mitral ﬂow
Variables Patient (n¼50) Control (n¼47) P value
E (m/sn) 0.83  0.14 0.90  0.14 0.022
A (m/sn) 0.75  0.17 0.73  0.10 0.50
E/A ratio 1.1  0.30 1.2  0.20 0.166
DT (ms) 215  44 166  26 <0.001
IVCT (ms) 65.7  13.9 69.8  12.2 0.127
ET (ms) 286  28 282  29 0.475
IVCT/ET ratio 0.22  0.04 0.26  0.04 0.057
IVRT (m/s) 84.9  12.5 70.2  13.6 <0.001
MPI 0.50  0.10 0.49  0.08 0.553
E, early diastolic wave; A, late diastolic wave; DT, deceleration time; _IVCZ, isovolumetric
contraction time; ET, ejection time; _IVRT, isovolumetric contraction time; MPI, myocardial
performance index
Sm 0.35 <0.001 0.36 <0.001
Em 0.42 <0.001 0.44 <0.001
Am 0.12 0.24 0.11 0.27
Em/Am ratio 0.26 0.008 0.26 0.009
IVCTm -0.08 0.41 0.02 0.83
ETm 0.01 0.92 -0.07 0.50
IVRTm -0.36 <0.001 -0.22 0.02
MPI -0.24 -0.24 -0.008 0.44
Sm, systolicmyocardial wave; Em, early diastolicmyocardialwave; Am, late diastolicmyocardial
wave; IVCTm,myocardial isovolumetric contraction time; ETm:myocardial ejektion time; IVRTm,
myocardial isovolumetric contraction time; MPI, myocardial performance index
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Introductıon: Cardiovascular disease is the leading cause of death among patients
with end-stage renal disease (ESRD). Arterial stiffness (AS) is an independent
predictive parameter for overall and cardiovascular mortality in these patients.
However, the deﬁned procedures for the measurement of AS are time consuming and
not practical in daily practice.
Methods: The study population included 50 patients with ESRD who treated with
hemodialysis (n: 23) or peritoneal dialysis (n: 27) and age- and sex-matched 70 control
groups. Aortofemoral pulse-wave velocity (PWV), carotid intima media thickness
(CIMT) and color M-mode propagation velocity of the descending aorta (aortic
propagation velocity, AVP) were measured.
Results: Compared to patients with control groups, patients having ESRD had
signiﬁcantly lower AVP (46.412.4 vs 58.58.5, p<0.01), and higher PWV
(10.52.5 vs 9.21.2, p<0.01) and CIMT (0.66  0.15 vs 0.43  0.06, p<0.01)
measurements. There were signiﬁcant correlations between AVP and CIMTERS C171
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S(r¼-0.769, P<0.001), AVP and PWV (r¼-0.682, P<0.001), and PWV and CIMT
(r¼0.564, P<0.001). There were no signiﬁcant differences in AVP, PWV and
between PD and HD patients.
Conclusıon: Arterial stiffness which is an important indicator of atherosclerosis
and arterial aging in patients with ESRD. The measurement of AVP is an easy
and practical new echocardiographic method may be used identifying AS in these
patients.Table 1
ESRD Control grups P-value
age, y 42.5  16.3 37.9  12.6 NS
men, n (%) 23 (46.0) 32 (45.7) NS
hypertension, n (%) 22 (44) 15 (21.4) <0.05
diabetes, n (%) 10 (20) 7 (10) NS
smoking 12 (24) 21 (30) NS
BMI, kg/m2 26.5  5.0 24.6  5.4 NS
SBP, mmHg 123.2  21.4 112.0  11.4 <0.05
DBP, mmHg 77.8  14.5 70.2  8.4 <0.05
total cholesterol (mg/dL) 185.8  58.7 175.5  37.6 NS
LDL-cholesterol (mg/dL) 109.9  37.0 102.1  29.5 NS
HDL-cholesterol (mg/dL) 39.4  10.7 42.7  10.0 NS
Tryglyceride (mg/dL) 215.8  122.3 184.9  102.9 NS
DT (msec) 253.4  66.7 204.9  32.2 <0.01
IVRT (msec) 116.6  18.3 87.5  13.6 <0.01
LV ejection fraction(%) 63.5  4.3 64.5  3.0 NS
Clinical and echocardiographic characteristics of patients with ESRD and control groups
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Table 2
ESRD Control grups P-value
AVP (cm/sec) 46.4  12.4 58.5  8.5 <0.01
CIMT (mm) 0.65  0.14 0.43  0.06 <0.01
PWV (m/s) 10.5  2.5 9.2  1.2 <0.01
Comparison of measured AVP, PWV and CIMT in patients with ESRD and control groups.
Table 3
HD PD P value
AVP (cm/sec) 47.0  9.6 46.0  14.6 NS
CIMT (mm) 0.71  0.14 0.61  0.13 NS
PWV (m/s) 10.3  2.9 10.7  2.0 NS
Comparison of measured AVP, PWV and CIMT in patients treated with haemodialysis and
Peritoneal dialysis.
Comparison of baseline, laboratory and echocardiographic characteristics
among the groups
Variables
Control
Group NG Group CR Group EH Group CH group P value
Age
(year)
51.34.7 52.94.1a 50.85.1 52.24.0 51.07.6 0.770
Gender
(male)
20 (45.5%) 40 (46.0%) 33 (45.8%) 21 (37.5%) 42 (46.2%) 0.852N
Hs-
Troponin T,
pg/ml
4.461.0 4.721.3 5.02.1 6.02.7 9.53.3 <0.001
Creatinin,
mg/dl
0.71
0.17k
0.73
0.13kk
0.890.14 0.770.11 0.910.11 <0.001
RWth 0.370.05 0.360.05 0.500.04 0.390.04 0.530.06 <0.001
LVMI 88.614.0 88.010.7 96.411.4 126.610.3 148.623.9 <0.001
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Aim: The aim of this study was to assess subclinical the left and right ventricular
dysfunction by using novel load-independent tissue Doppler imaging (TDI) derived
isovolumic myocardial acceleration (IVA) in metabolic syndrome (MetS) patients and
the association of this impairment with the number of MetS components.
Methods: The study included 133 subjects divided into two groups: 75 patients with
MetS and a control group (n ¼ 58) without MetS. MetS was deﬁned by the presence
of 3 ATP-NCEP III criteria. All the subjects underwent laboratory blood tests and
complete conventional echocardiography and TDI.
Results: There were no signiﬁcant changes in traditional echocardiographic param-
eters. The diastolic and global functions of both ventricles (early (E') and late (A')
diastolic velocities, E'/A' ratio, myocardial performance index) were signiﬁcantly
impaired (p<0.05). The TDI-derived IVA of the right vetricular (RV) and the left
ventricular (LV) was signiﬁcantly lower in patients with MetS (3.20.9 vs 4.01.4,
p<0.001 and 2.60.7 vs 3.10.9, p¼0.001). Whereas TDI derived systolic velocity
(Sa), and peak myocardial velocity during isovolumic contraction (IVV) of both
ventricles were similar between the two groups (p>0.05 for all). The IVA of the LV
was inversely correlated with the patient's waist circumference (r¼ -0.28, p¼0.001),
triglyceride levels (r¼ -0.22, p¼0.014), and the number of risk factors (r¼ - 0.28,
p¼0.001). The RV IVA was inversely correlated with diastolic blood pressure (r¼
-0.37, p¼<0.001) and systolic blood pressure (r¼ -26, p¼0.003), triglyceride levels
(r¼ -0.29, p¼0.001), and the number of risk factors (r¼ -0.28, p¼ 0.001) and
correlated with HDL cholesterol (r¼ 0.24, p¼0.001).
Conclusıons: MetS is associated with subclinical systolic dysfunction of both the RV
and the LV. More severe MetS was associated with increasingly compromised left
ventricular and right ventricular function.
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Background: The high-sensitivity cardiac troponin T (hs-cTnT) assay provides
important prognostic information in cardiovascular diseases. Although hs-cTnT is
associated with left ventricle (LV) hypertrophy, hs-cTnT levels have not been
investigated in different LV geometric patterns incorporating normal LV structure and
concentric remodelling in addition to LV hypertrophy.
Objectıves: We aimed to investigate the possible association between hs-cTnT and
LV geometric patterns in newly diagnosed hypertensive patients.
Methods: We studied 306 patients with newly diagnosed HT (mean age 51.7  5.4
years) and 44 healthy control subjects (mean age 51.2  5.1 years). Echocardio-
graphic examination was performed in all subjects. Four different geometric patterns
were determined in hypertensive patients according to LV mass index (LVMI) andJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTrelative wall thickness (RWT). Hs-cTnT and other biochemical markers were
measured in all participants.
Results: The highest hs-cTnT values were observed in concentric hypertrophy group
compared with control, normal geometry, concentric remodelling and eccentric
hypertrophy groups (p<0.05, for all). Also, hs-cTnT values of eccentric hypertrophy
group were higher than control, normal geometry and concentric remodelling groups
(p<0.05, for all). Multivariate regression analysis showed that hs-cTnT was inde-
pendently associated with LV geometry (b¼0.326, p¼0.001) as well as LVMI
(b¼0.228, p¼0.010) and creatinin level(b¼.0.132, p¼0.012).
Conclusıon: Hs-cTnT levels related with not only LV hypertrophy but also LV
geometry in hypertensive patients. Hs-cTnT levels may mediate poor prognosis in
hypertensive patients including different LV geometric patterns.PP-224
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Objectıve: Increased echocardiographically measured epicardial adipose tissue (EAT)
thickness is linked with worse prognosis in variety of cardiovascular diseases.
Previous studies demonstrated that EAT thickness is increased in patients with
hypertension compared with normotensive individuals. In the current studu we aimed
to evaluate whether echocardiographically measured EAT thickness differ between the
patients with pre-hypertension and normotensive healthy subjects.
Methods: Seventy patients who were diagnosed with prehypertension for the ﬁrst
time by the Joint National Committee 7 criteria and 50 normotensive healthy controls
were included to the study. Each participant underwent comprehensive transthoracic
echocardiographic examination. EFT thickness was measured from parasternal long-
axis view at end-systole, along the mid-line of the ultrasound beam and parallel to the
aortic valve annulus plane.
Results: In patients with prehypertension, EAT thickness was signiﬁcantly increased
compared with normotensives (5.71.6 mm versus 4.11.5 mm, p<0.001). After
adjustment for age, gender, serum high density lipoprotein, hemoglobin and mitral
inﬂow E/A ratio level, mean EAT thickness values were calculated higher in pre-
hypertensive group than normotensive group (5.31.7 versus 4.31.4, p¼0.002).
Both systolic and diastolic ofﬁce blood pressures were signiﬁcantly related with EAT
thickness (r¼0.348 and r¼0.315, respectively; p<0.001).
Conclusıon: Echocardiographically measured EAT thickness is higher in pre-
hypertensives compared with normotensive controls independently of each other
factors. Moreover, increased EAT thickness is signiﬁcantly correlated with ofﬁce
systolic and diastolic blood pressure levels.
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Background: Lead (Pb), one of the oldest known metals, is a pervasive and persistent
environmental occupational toxic metal, and Pb poisoning remains a health threat.
Neurologic, hematologic, gastrointestinal and renal toxicity are well known but
cardiac toxicity has not been investigated.The aim of present study was to investigate
the effect of cardiac toxicity of lead especially on echocardiographic parameters.
Methods: A total of 106 patients,admitted to hospital in Ankara Occupational
Diseases in 2012 because of lead exposure were included in the study.Patients withERS C173
